{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:07:34Z","timestamp":1794276454964,"version":"4.9.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05230-8","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:35:29Z","timestamp":1785972929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated atherogenic index of plasma in multiple sclerosis: association with metabolic profile in a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1307-3578","authenticated-orcid":false,"given":"Nimet","family":"Ucaroglu Can","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-6321","authenticated-orcid":false,"given":"Dilcan","family":"Kotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"9648","key":"5230_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7.","journal-title":"Lancet"},{"key":"5230_CR2","doi-asserted-by":"publisher","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4. Erratum in: Nat Rev Dis Primers. 2018;4(1):49. doi:10.1038\/s41572-018-0050-3.","DOI":"10.1038\/s41572-018-0041-4"},{"issue":"6","key":"5230_CR3","doi-asserted-by":"publisher","first-page":"103088","DOI":"10.1016\/j.autrev.2022.103088","volume":"21","author":"B Lorincz","year":"2022","unstructured":"Lorincz B, Jury EC, Vrablik M, Ramanathan M, Uher T. The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity. Autoimmun Rev. 2022;21(6):103088. https:\/\/doi.org\/10.1016\/j.autrev.2022.103088.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5230_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms25010131","volume":"25","author":"J Wei","year":"2023","unstructured":"Wei J, Wong LC, Boland S. Lipids as Emerging Biomarkers in Neurodegenerative Diseases. Int J Mol Sci. 2023;25(1):131. https:\/\/doi.org\/10.3390\/ijms25010131.","journal-title":"Int J Mol Sci"},{"key":"5230_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1742-2094-8-127","volume":"8","author":"B Weinstock-Guttman","year":"2011","unstructured":"Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8:127. https:\/\/doi.org\/10.1186\/1742-2094-8-127.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5230_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12944-020-01221-x","volume":"19","author":"\u017d R\u00e1dikov\u00e1","year":"2020","unstructured":"R\u00e1dikov\u00e1 \u017d, Penesov\u00e1 A, Vl\u010dek M, Havranov\u00e1 A, Siv\u00e1kov\u00e1 M, \u0160iarnik P, \u017dit\u0148anov\u00e1 I, Imrich R, Tur\u010d\u00e1ni P, Koll\u00e1r B. Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation? Lipids Health Dis. 2020;19(1):49. https:\/\/doi.org\/10.1186\/s12944-020-01221-x.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"5230_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019;50(5):285\u201394. https:\/\/doi.org\/10.1016\/j.arcmed.2019.08.009.","journal-title":"Arch Med Res"},{"issue":"4","key":"5230_CR8","doi-asserted-by":"publisher","first-page":"205521731988272","DOI":"10.1177\/2055217319882720","volume":"5","author":"S Blumenfeld-Kan","year":"2019","unstructured":"Blumenfeld-Kan S, Staun-Ram E, Golan D, Miller A. HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis. Mult Scler J Exp Transl Clin. 2019;5(4):2055217319882720. https:\/\/doi.org\/10.1177\/2055217319882720.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"5230_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.msard.2015.10.005","volume":"5","author":"S Zhornitsky","year":"2016","unstructured":"Zhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53\u201365. https:\/\/doi.org\/10.1016\/j.msard.2015.10.005.","journal-title":"Mult Scler Relat Disord"},{"key":"5230_CR10","doi-asserted-by":"publisher","first-page":"1472267","DOI":"10.3389\/fendo.2025.1472267","volume":"16","author":"X Su","year":"2025","unstructured":"Su X, Zhao C, Li D, Zhang X. Association between the atherogenic index of plasma and abdominal aortic calcification: results from the National Health and Nutrition Examination Survey 2013\u20132014. Front Endocrinol (Lausanne). 2025;16:1472267. https:\/\/doi.org\/10.3389\/fendo.2025.1472267.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5230_CR11","doi-asserted-by":"publisher","first-page":"2442532","DOI":"10.1080\/07853890.2024.2442532","volume":"57","author":"S Jiang","year":"2025","unstructured":"Jiang S, Liu S, Xiao G, Liu K, Li J. Atherogenic index of plasma and the clinical outcome of patients with acute coronary syndrome: a meta-analysis. Ann Med. 2025;57(1):2442532. https:\/\/doi.org\/10.1080\/07853890.2024.2442532.","journal-title":"Ann Med"},{"issue":"10","key":"5230_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4.","journal-title":"Lancet Neurol"},{"key":"5230_CR13","doi-asserted-by":"publisher","first-page":"105841","DOI":"10.1016\/j.msard.2024.105841","volume":"91","author":"TR Wicks","year":"2024","unstructured":"Wicks TR, Nehzat N, Wolska A, Shalaurova I, Browne RW, Weinstock-Guttman B, Jakimovski D, Zivadinov R, Remaley AT, Otvos J, Ramanathan M. Dyslipidemias in multiple sclerosis. Mult Scler Relat Disord. 2024;91:105841. https:\/\/doi.org\/10.1016\/j.msard.2024.105841.","journal-title":"Mult Scler Relat Disord"},{"key":"5230_CR14","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.5114\/amsad\/204578","volume":"10","author":"A Makris","year":"2025","unstructured":"Makris A, Palli N, Liontos A, Rizos EC, Tsioutis C, Papadopoulos D, Agouridis AP. High-density lipoprotein cholesterol and multiple sclerosis: a systematic review and meta-analysis. Arch Med Sci Atheroscler Dis. 2025;10:e69\u201377. https:\/\/doi.org\/10.5114\/amsad\/204578.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"5230_CR15","doi-asserted-by":"publisher","unstructured":"Oliveira SR, Kallaur AP, Lopes J, Colado Sim\u00e3o AN, Reiche EM, de Almeida ERD, Morimoto HK, de Pereira C, Alfieri WL, Flauzino DF, de Meleck Proen\u00e7a T, Gomes C, Kaimen-Maciel AM, Maes DR. M. Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid. Psychiatry Res. 2017;250:113\u2009\u2013\u200920. https:\/\/doi.org\/10.1016\/j.psychres.2016.12.039","DOI":"10.1016\/j.psychres.2016.12.039"},{"issue":"2","key":"5230_CR16","doi-asserted-by":"publisher","first-page":"205521732412386","DOI":"10.1177\/20552173241238627","volume":"10","author":"RA Marrie","year":"2024","unstructured":"Marrie RA, Patel R, Schaffer SA. Subclinical atherosclerosis in multiple sclerosis. Mult Scler J Exp Transl Clin. 2024;10(2):20552173241238627. https:\/\/doi.org\/10.1177\/20552173241238627.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"13","key":"5230_CR17","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1177\/1352458514533162","volume":"20","author":"P Tettey","year":"2014","unstructured":"Tettey P, Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Dwyer T, Kostner K, van der Mei I. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler. 2014;20(13):1737\u201344. https:\/\/doi.org\/10.1177\/1352458514533162.","journal-title":"Mult Scler"},{"issue":"4","key":"5230_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/13524585251325468","volume":"31","author":"R Noroozi","year":"2025","unstructured":"Noroozi R, Tsai HH, Yu K, Bronson P, Samuel K, Trinh K, Wei R, Tsai E, Briggs FB, Bhargava P, Fitzgerald KC. Metabolic and lipid alterations in multiple sclerosis linked to disease severity. Mult Scler. 2025;31(4):433\u201343. https:\/\/doi.org\/10.1177\/13524585251325468.","journal-title":"Mult Scler"},{"issue":"4","key":"5230_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11481-020-09937-4","volume":"15","author":"I Rauma","year":"2020","unstructured":"Rauma I, Huhtala H, Soilu-H\u00e4nninen M, Kuusisto H. Lipid Profile Alterations during Fingolimod Treatment in Multiple Sclerosis Patients. J Neuroimmune Pharmacol. 2020;15(4):567\u20139. https:\/\/doi.org\/10.1007\/s11481-020-09937-4.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"5230_CR20","first-page":"472","volume":"39","author":"H Dogan","year":"2014","unstructured":"Dogan H, Yilmaz F, Uysal S, Mungan S, Ak F. Serum lipids and Lp-PLA2 activity in multiple sclerosis. Turk J Biochem. 2014;39(4):472\u20135.","journal-title":"Turk J Biochem"},{"key":"5230_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","volume":"11","author":"M Magyari","year":"2020","unstructured":"Magyari M, Sorensen PS. Comorbidity in Multiple Sclerosis. Front Neurol. 2020;11:851. https:\/\/doi.org\/10.3389\/fneur.2020.00851.","journal-title":"Front Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05230-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:44Z","timestamp":1791544244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05230-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5230"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05230-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Sakarya University Faculty of Medicine Ethics Committee (approval number: E-43012747-050.04-567425-108; date: February 25, 2026). The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study, the requirement for informed consent to participate was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"640"}}